Severe Embryotoxicity of Artemisinin Derivatives in Experimental Animals, but Possibly Safe in Pregnant Women
Preclinical studies in rodents have demonstrated that artemisinins, especially injectable artesunate, can induce fetal death and congenital malformations at a low dose range. The embryotoxicity can be induced in those animals only within a narrow window in early embryogenesis. Evidence was presented...
Main Authors: | Qigui Li, Peter J. Weina |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2009-12-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/15/1/40/ |
Similar Items
-
Artemisinin anti-malarial drugs in China
by: Zongru Guo
Published: (2016-03-01) -
Population pharmacokinetics of artesunate and dihydroartemisinin in children and pregnant women with malaria
by: Morris, Carrie Ann
Published: (2014) -
New Uses for Old Drugs: The Tale of Artemisinin Derivatives in the Elimination of Schistosomiasis Japonica in China
by: Yi-Xin Liu, et al.
Published: (2014-09-01) -
Population pharmacokinetics of artesunate and its active metabolite dihydroartemisinin
by: Tan, Bee San
Published: (2009) -
Population pharmacokinetics and pharmacodynamics of the artesunate–mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children
by: Monia Guidi, et al.
Published: (2019-04-01)